Baricitinib 4mg tablets
NHS hospitals in England used £38,145,660 of indicative cost of Baricitinib 4mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 9.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Baricitinib 4mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Baricitinib 4mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Lancashire Care Nhs Foundation Trust | £2,109,762 |
| The Royal Wolverhampton Nhs Trust | £1,337,230 |
| Sheffield Teaching Hospitals Nhs Trust | £889,597 |
| The Hillingdon Hospitals Nhs Ft | £811,199 |
| University Hpls Of Leicester Nhs Trust | £773,798 |
| Western Sussex Hospitals Nhs Found Trust | £747,588 |
| Leeds Teaching Hpls Nhs Trust | £742,870 |
| St Helens & Knowsley Hospitals Nhs Trust | £711,309 |
| Oxford University Hospitals Nhs Ft | £675,203 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £674,369 |
The primary-care picture
Baricitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Baricitinib medicine page.